Could I am not going to dispute the fact that if Pfizer owned Amarin, they would have been able to pour $100 million into promoting V and had sales doubled by now. Amarin doesn’t have the cash to do this. Bottom line: Pfizer hasn’t made an offer. I guarantee you Pfizer knows all there is to know about V (they sell it in Canada) so how would Denner change their mind - other than dropping the price to get their interest
could, corporate decisions emerge from more than your paint-by-numbers mental picture. BP isn't in the business of accomplishing anything that happens to align with your ill-defined long thesis. BP is in the business of pushing the drug candidates driving career trajectories across their corporate chain of command.